C4 Therapeutics accounting officer sells 93% of holding
Alpha Vantage · Simply Wall St · · AI-summarised by FinFlash
Kendra Adams, Principal Accounting Officer of C4 Therapeutics (NASDAQ:CCCC), sold US Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context